PREVENT WITH QULIPTA
FOR MIGRAINE
PREVENTION
Not actual size.
In a 3-month study,
QULIPTA reduced monthly
migraine days.
MAJORITY OF PEOPLE REDUCED
MONTHLY MIGRAINE DAYS BY
50% TO 100%
Up to 8% of people achieved complete migraine
reduction over the entire 3 months.

WHAT IS QULIPTA®?

QULIPTA (atogepant) is a prescription medicine used for
the preventive treatment of episodic migraine in adults.

IMPORTANT SAFETY INFORMATION

Before taking QULIPTA, tell your healthcare provider
about all your medical conditions, including if you:

Have kidney problems or are on dialysis

Have liver problems

Are pregnant or plan to become pregnant. It is not
known if QULIPTA will harm your unborn baby

Are breastfeeding or plan to breastfeed. It is not
known if QULIPTA passes into your breast milk. Talk to
your healthcare provider about the best way to feed
your baby while taking QULIPTA

Tell your healthcare provider about all the medicines
you take,
including prescription and over-the-counter
medicines, vitamins, and herbal supplements. QULIPTA
may affect the way other medicines work, and other
medicines may affect how QULIPTA works. Your
healthcare provider may need to change the dose of
QULIPTA when taken with certain other medicines.

The most common side effects of QULIPTA are nausea,
constipation, and tiredness. These are not all the
possible side effects of QULIPTA.

Please see full Patient Information.

You are encouraged to report negative side effects of
prescription drugs to the FDA. Visit www.fda.gov/
medwatch
or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine,
AbbVie may be able to help. Visit AbbVie.com/
myAbbVieAssist
to learn more.

© 2022 AbbVie. All rights reserved.

All trademarks are the property of their
respective owners.

US-QLP-220337 12/22

INDICATION AND IMPORTANT SAFETY INFORMATION
PLEASE CLICK HERE FOR FULL PATIENT INFORMATION